Synthesis, Cytotoxic Activity Evaluation and Molecular Docking Studies of Some Benzimidazole Derivatives
Abstract
In this study, the synthesis of 2-(2-acetyl-1H-benzimidazol-1-yl)-1-arylethanone (3a-3d) and 1-methyl-3-phenyl-benzo[4,5]imidazo[1,2-a]pyrazine derivatives (4a-4d) and to investigate their cytotoxic activity were aimed. APCI, IR, 1HNMR, and 13CNMR spectra were utilized to determine the structure of the synthesized compounds. The cytotoxic activity of selected compounds were detected in A549 (human lung carcinoma) and NIH3T3 (mouse embryonic fibroblasts) cell lines. Compounds 4c and 4d were found to be selectively cytotoxic against A549 and NIH3T3 cell lines. Molecular docking studies were performed using the data retrieved from the Protein Data Bank server (PDBID: 4QTX).
Keywords
Benzimidazole, Pyrazinobenzimidazole, Anticancer, Molecular docking
Thanks
Our authors express their gratitude to the Herbal, Pharmaceutical, and Scientific Research Application and Research Center (AUBİBAM).
References
- [1] M. Hou, H.C. Li, N. An, S.Y. Pang, W.G. Li, J. Tong, Synthesis, crystal structures and anticancer studies of Ni (Ⅱ), Co (Ⅲ) and Zn (Ⅱ) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base, J. Mol. Struct., 1294 (2023) 136500.
- [2] The top 10 causes of death, (n.d.). https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed November 15, 2023).
- [3] D. Nuha, A.E. Evren, Z.Ş. Çiyanci, H.E. Temel, G. Akalin Çiftçi, L. Yurttaş, Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity, Arch Pharm (Weinheim), 355 (2022).
- [4] İ. Celik, G. Ayhan-Kılcıgil, B. Guven, Z. Kara, A.S. Gurkan-Alp, A. Karayel, A. Onay-Besikci, Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors, Eur. J. Med. Chem., 173 (2019) 240–249.
- [5] A.E. Evren, L. Yurttaş, B. Eksellı, G. Akalın-Cıftcı, Novel Tri-substituted Thiazoles Bearing Piperazine Ring: Synthesis and Evaluation of their Anticancer Activity, Lett Drug Des Discov 16 (2019) 547–555. https://doi.org/10.2174/1570180815666180731122118. A. Sharma, V. Luxami, K. Paul, Purine-benzimidazole hybrids: Synthesis, single crystal determination and in vitro evaluation of antitumor activities, Eur. J. Med. Chem., 93 (2015) 414–422.
- [6] G. Satija, B. Sharma, A. Madan, A. Iqubal, M. Shaquiquzzaman, M. Akhter, S. Parvez, M.A. Khan, M.M. Alam, Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets, J. Heterocycl Chem., 59 (2022) 22–66.
- [7] R. Singla, K.B. Gupta, S. Upadhyay, M. Dhiman, V. Jaitak, Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α), Eur. J. Med. Chem., 146 (2018) 206–219..
- [8] T.S. Reddy, H. Kulhari, V.G. Reddy, V. Bansal, A. Kamal, R. Shukla, Design, synthesis and biological evaluation of 1,3-diphenyl-1 H -pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents, Eur. J. Med. Chem., 101 (2015) 790–805.
- [9] M.L. Di Gioia, R. Cassano, P. Costanzo, N. Herrera Cano, L. Maiuolo, M. Nardi, F.P. Nicoletta, M. Oliverio, A. Procopio, Green Synthesis of Privileged Benzimidazole Scaffolds Using Active Deep Eutectic Solvent, Molecules, 24 (2019) 2885.
- [10] K. Laxmikeshav, A. Himaja, N. Shankaraiah, Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution, J. Mol. Struct., 1253 (2022) 132251.